CUSIP: 75973T101
Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
5,685,796
-
Share change
-
-641,187
-
Total reported value
-
$13,929,330
-
Price per share
-
$2.45
-
Number of holders
-
31
-
Value change
-
-$2,019,598
-
Number of buys
-
12
-
Number of sells
-
17
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2022
-
Previous quarter:
Q1 2022
Recent filing periods for CUSIP 75973T101:
Institutional Holders of Renalytix plc - ADS (RNLXY) as of Q2 2022
As of 30 Jun 2022,
Renalytix plc - ADS (RNLXY) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,685,796 shares.
The largest 10 holders included
GILDER GAGNON HOWE & CO LLC, Philosophy Capital Management LLC, GW&K Investment Management, LLC, Parian Global Management LP, PINNACLE ASSOCIATES LTD, Granahan Investment Management, LLC, FRED ALGER MANAGEMENT, LLC, LAZARD ASSET MANAGEMENT LLC, Pentwater Capital Management LP, and GOFEN & GLOSSBERG LLC /IL/.
This page lists
31
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.